Indicator | Comparison A comparison between a company and a defined peer group. Learn More ↗ Opens in a New Tab | Rank |
|---|---|---|
Revenue | 1,018,984 € | 26 / 460+309.4% |
Net Profit | -334,259 € | 463 / 480-134.7% |
Assets | 546,158 € | 69 / 476-2.9% |
Company Age | 4 years · | 354 / 495 |
Net profit as a share of revenue.
Equity as a share of total assets.
Indicator | 2025Latest | 2024 | 2023 |
|---|---|---|---|
Revenue | 1,018,984 € +309.4% | 248,916 € | 0 € |
Net Profit | -334,259 € -134.7% | -142,411 € | -124,085 € |
Assets | 546,158 € -2.9% | 562,221 € | 3,756 € |
LiabilitiesAmounts a company owes to lenders, suppliers, and other creditors. Learn More ↗ Opens in a New Tab | 1,140,117 € +38.7% | 821,921 € | 121,045 € |
EquityAssets remaining after all company liabilities are deducted. Learn More ↗ Opens in a New Tab | -593,959 € -128.7% | -259,700 € | -117,289 € |
EmployeesThe reported number of employees for the accounting period. Learn More ↗ Opens in a New Tab | 0 | 0 | 0 |
Industry | Code | Share | Revenue |
|---|---|---|---|
Research and Experimental Development on Natural Sciences and Engineering | 72.10 | 100.0% | 1,018,984 € |
Country | Share | Revenue |
|---|---|---|
Countries Outside the EU | 89.7% | 914,074 € |
Latvia | 10.3% | 104,910 € |
Name | Born | Roles A registered connection between a person or organisation and a company. Learn More ↗ Opens in a New Tab | |
|---|---|---|---|
- | Contact Person | ||
Board Member | |||
- | Board Member | ||
- | Board Member | ||
- | Shareholder 100.00% | ||
- | Beneficial Owner | ||
- | Founder | ||
- | Founder |
Name | Born | Nationality | Registered | |
|---|---|---|---|---|
- | - |
Name | Registered | Until |
|---|---|---|
- | ||
- |
Name | Born | Position | Registered | |
|---|---|---|---|---|
- | ||||
- | ||||
- |
Category | Scope | Number | Status | Expiry |
|---|---|---|---|---|
Medical Devices | · EU medical-device regulated actor | EE-MF-000024299 | Valid | - |
Value | Record | Date |
|---|---|---|
Manufacturer | EUDAMED Actor Registration | - |
Efferon® NEO | EUDAMED Device Registration | - |
Efferon® LPS | EUDAMED Device Registration | - |
In 2025: revenue 1 million €, loss 334.3 thousand €, no employees. Share capital 45,000 €. Beneficial owner: Natalia Romashina.